Retrospective Analysis of Veritas in Breast Reconstruction
NCT ID: NCT01454713
Last Updated: 2017-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2010-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective Assessment of OviTex PRS (OviTex)
NCT05736848
Effectiveness and Safety of OviTex® PRS in Breast Reconstruction
NCT07135596
A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction
NCT02985073
Following the Use of Gel Prosethetics in Breast Reconstruction
NCT00585884
Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived Urethane Adhesive
NCT03159598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Veritas
Breast reconstruction with Veritas
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who underwent mastectomy with immediate breast reconstruction using Veritas collagen matrix
* Patients who underwent mastectomy with single stage procedures or two-stage procedures using Veritas collagen matrix
Exclusion Criteria
* Reconstruction with something other than Veritas collagen matrix
* Breasts that were created with DIEP or TRAM procedures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Synovis Surgical Innovations
INDUSTRY
Baxter Healthcare Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark M Mofid, MD
Role: PRINCIPAL_INVESTIGATOR
UCSD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mark M. Mofid, MD
San Diego, California, United States
Michael Meininger, MD
Troy, Michigan, United States
Martin Lacey, MD
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.